The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive mutation analysis in NRG Oncology/RTOG 9813: A phase III trial of RT + TMZ vs RT + nu for anaplastic astrocytoma and mixed anaplastic oligoastrocytoma (Astrocytoma Dominant).
 
Erica Hlavin Bell
Patents, Royalties, Other Intellectual Property - MIRNA-BASED PREDICTIVE MODELS FOR DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER Patent Pending; REVISED RECURSIVE PARTITIONING ANALYSIS (RPA) MODEL FOR GLIOBLASTOMA PATENT PENDING
 
Joseph P McElroy
No Relationships to Disclose
 
Jessica Fleming
No Relationships to Disclose
 
Cynthia Dawn Timmers
Stock and Other Ownership Interests - ARIAD; Array BioPharma; Seagen
 
Arup R Chakraborty
No Relationships to Disclose
 
Andrea L Salavaggione
No Relationships to Disclose
 
Susan Marina Chang
Consulting or Advisory Role - Neonc Technologies
Research Funding - Agios (Inst); Novartis (Inst); Quest diagnostics (Inst); Schering-Plough Research Institute (Inst)
 
Kenneth D. Aldape
Consulting or Advisory Role - Celldex
 
David Brachman
Stock and Other Ownership Interests - GammaTile
Patents, Royalties, Other Intellectual Property - Gammatile, LLC
Other Relationship - GammaTile
 
Helen Alice Shih
Consulting or Advisory Role - Genentech
 
Peixin Zhang
No Relationships to Disclose
 
Minesh P. Mehta
Leadership - Pharmacyclics
Stock and Other Ownership Interests - Pharmacyclics
Honoraria - Ca Progress; Elekta; EMD Serono; Research to Practice
Consulting or Advisory Role - Bristol-Myers Squibb; Cavion; Celldex; Elekta; Novartis; Novocure; Roche/Genentech
Research Funding - Novelos (Inst); Novocure (Inst)
Other Relationship - Monteris Medical
 
Arnab Chakravarti
Patents, Royalties, Other Intellectual Property - Correlation of molecular markers with clinical outcome in GBM patients treated with and without Gefitinib; MIRNA-BASED PREDICTIVE MODELS FOR DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER PATENT PENDING; REVISED RECURSIVE PARTITIONING ANALYSIS (RPA) MODEL FOR GLIOBLASTOMA PATENT PENDING